SynthesisFrontiers in medicine2022
Livedoid vasculopathy - A diagnostic and therapeutic challenge.
Synthesis in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 27 citations in OpenAlex.
- A Double Diagnosis Behind Chronic Ulcers: Livedoid Vasculopathy With Acroangiodermatitis in an Elderly Woman.Cureus · 2026Article
- Exosome Therapy for Livedoid Vasculitis Following COVID-19 Vaccination: A Case Report.Drug, healthcare and patient safety · 2026Article
- Refractory livedoid vasculopathy successfully treated with immunosuppressive therapy.JAAD case reports · 2025Article
- Successful healing of a chronic ulcer in livedoid vasculopathy using PuraPly: A case report.JAAD case reports · 2025Article
- Deltoid compartment syndrome and pulmonary embolism following arthroscopic rotator cuff repair.JSES reviews, reports, and techniques · 2025Article
- Clinical Characteristics and Disease Course of Livedoid Vasculopathy: A 10-Year Retrospective Analysis.Clinical, cosmetic and investigational dermatology · 2025Article
- Prevalence of Livedoid Vasculopathy Among Patients with Connective Tissue Diseases and Its Association with Thrombophilic Factors: A Hospital-Based Retrospective Cohort (2014-2021).Clinical, cosmetic and investigational dermatology · 2025Article
- Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.Rheumatology (Oxford, England) · 2024Review
- Healing refractory livedoid vasculopathy-related skin ulcers by ozone therapy: a case-based review.Rheumatology international · 2024Review
- The Histopathology of Leg Ulcers.Dermatopathology (Basel, Switzerland) · 2024Review
- Identification of Challenging Diagnostic Factors in Livedoid Vasculopathy: A Retrospective Study.Clinical, cosmetic and investigational dermatology · 2024Article
- Article
- Evaluating complement dysregulation in livedoid vasculopathy using a functional assay.Blood advances · 2023Article
- Impact of neutrophil extracellular traps on fluid properties, blood flow and complement activation.Frontiers in immunology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Livedoid vasculopathy is a rare, chronic-recurrent occlusive disorder in the microcirculation of dermal vessels. The clinical appearance is characterized by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.